237 related articles for article (PubMed ID: 21044244)
1. Irreversible electroporation (IRE): a novel method for renal tissue ablation.
Tracy CR; Kabbani W; Cadeddu JA
BJU Int; 2011 Jun; 107(12):1982-7. PubMed ID: 21044244
[TBL] [Abstract][Full Text] [Related]
2. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
[TBL] [Abstract][Full Text] [Related]
3. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study.
Pech M; Janitzky A; Wendler JJ; Strang C; Blaschke S; Dudeck O; Ricke J; Liehr UB
Cardiovasc Intervent Radiol; 2011 Feb; 34(1):132-8. PubMed ID: 20711837
[TBL] [Abstract][Full Text] [Related]
4. Current limitations of radiofrequency ablation in renal cell carcinoma.
Jewett MA
Urologe A; 2004 Sep; 43 Suppl 3():S122-3. PubMed ID: 15164179
[No Abstract] [Full Text] [Related]
5. Comparative Effects of Irreversible Electroporation, Radiofrequency Ablation, and Partial Nephrectomy on Renal Function Preservation in a Porcine Solitary Kidney Model.
Morgan MS; Ozayar A; Lucas E; Friedlander JI; Shakir NA; Cadeddu JA
Urology; 2016 Aug; 94():281-7. PubMed ID: 27155310
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of small renal tumors.
Johnson DB; Cadeddu JA
Expert Rev Anticancer Ther; 2004 Feb; 4(1):77-83. PubMed ID: 14748659
[TBL] [Abstract][Full Text] [Related]
7. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.
Olweny EO; Kapur P; Tan YK; Park SK; Adibi M; Cadeddu JA
Urology; 2013 Mar; 81(3):679-84. PubMed ID: 23290141
[TBL] [Abstract][Full Text] [Related]
9. Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model.
Wendler JJ; Porsch M; Hühne S; Baumunk D; Buhtz P; Fischbach F; Pech M; Mahnkopf D; Kropf S; Roessner A; Ricke J; Schostak M; Liehr UB
Cardiovasc Intervent Radiol; 2013 Apr; 36(2):512-20. PubMed ID: 22893419
[TBL] [Abstract][Full Text] [Related]
10. Upper-Urinary-Tract Effects After Irreversible Electroporation (IRE) of Human Localised Renal-Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Ablate-and-Resect Study.
Wendler JJ; Pech M; Köllermann J; Friebe B; Siedentopf S; Blaschke S; Schindele D; Porsch M; Baumunk D; Jürgens J; Fischbach F; Ricke J; Schostak M; Böhm M; Liehr UB
Cardiovasc Intervent Radiol; 2018 Mar; 41(3):466-476. PubMed ID: 28929209
[TBL] [Abstract][Full Text] [Related]
11. Cryoablation versus radiofrequency ablation for renal tumor ablation: time to reassess?
Gervais DA
J Vasc Interv Radiol; 2013 Aug; 24(8):1135-8. PubMed ID: 23885912
[No Abstract] [Full Text] [Related]
12. Renal surgery--is technique more important than tumor or patient characteristics in preserving kidney function?
Goldfarb DA
J Urol; 2011 Feb; 185(2):383-4. PubMed ID: 21168169
[No Abstract] [Full Text] [Related]
13. Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma.
Nosnik IP; Mouraviev V; Nelson R; Polascik TJ
Urology; 2006 Dec; 68(6):1343.e1-3. PubMed ID: 17141824
[TBL] [Abstract][Full Text] [Related]
14. Conservative renal surgery. Has it a role in renal cell carcinoma?
Keane TE; Graham SD
Surg Oncol Clin N Am; 1995 Apr; 4(2):295-306. PubMed ID: 7796288
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
[TBL] [Abstract][Full Text] [Related]
16. Choice of operation for clinically localized renal tumor.
Nguyen CT; Campbell SC; Novick AC
Urol Clin North Am; 2008 Nov; 35(4):645-55; vii. PubMed ID: 18992618
[TBL] [Abstract][Full Text] [Related]
17. Management of small renal tumors with radiofrequency ablation.
Raj GV; Reddan DJ; Hoey MF; Polascik TJ
Urology; 2003 Jan; 61(1):23-9. PubMed ID: 12559260
[No Abstract] [Full Text] [Related]
18. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous imaging-guided radiofrequency ablation of small renal cell carcinoma: techniques and outcomes of 24 treatment sessions in 18 consecutive patients.
Popovic P; Surlan-Popovic K; Lukic S; Mijailovic M; Jankovic S; Kuhelj D
J BUON; 2011; 16(1):127-32. PubMed ID: 21674863
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.
Wagstaff PG; de Bruin DM; Zondervan PJ; Savci Heijink CD; Engelbrecht MR; van Delden OM; van Leeuwen TG; Wijkstra H; de la Rosette JJ; Laguna Pes MP
BMC Cancer; 2015 Mar; 15():165. PubMed ID: 25886058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
